Bio-Path Holdings annual free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
Bio-Path Holdings Free Cash Flow (FCF) History (BPTH)
Bio-Path Holdings reported −$15.1M in free cash flow for fiscal 2022, a decrease of $5.1M from the previous fiscal year.
View full Bio-Path Holdings company overviewBio-Path Holdings free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2022 | 2022-12-31 | −$15.1M | −$5.1M | — | — |
| 2021 | 2021-12-31 | −$10.0M | −$1.6M | — | — |
| 2019 | 2019-12-31 | −$8.4M | −$2.2M | — | — |
| 2018 | 2018-12-31 | −$6.1M | $2.4M | — | — |
| 2017 | 2017-12-31 | −$8.5M | −$9,000 | — | −22959.46% |
| 2016 | 2016-12-31 | −$8.5M | −$3.5M | — | −65276.92% |
| 2015 | 2015-12-31 | −$5.0M | −$1.1M | — | — |
| 2014 | 2014-12-31 | −$3.9M | −$1.6M | — | — |
| 2013 | 2013-12-31 | −$2.3M | −$319,756 | — | — |
| 2012 | 2012-12-31 | −$2.0M | — | — | — |
Bio-Path Holdings quarterly free cash flow
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q3.21
Q3.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | −$3.4M | −$1.2M | — | — |
| Q3 2021 | 2021-09-30 | −$2.9M | −$883,000 | — | — |
| Q4 2019 | 2019-12-31 | −$2.2M | −$962,000 | — | — |
| Q3 2019 | 2019-09-30 | −$1.9M | −$422,000 | — | — |
| Q2 2019 | 2019-06-30 | −$2.2M | −$509,000 | — | — |
| Q1 2019 | 2019-03-31 | −$2.0M | −$327,000 | — | — |
| Q4 2018 | 2018-12-31 | −$1.3M | $942,000 | — | — |
| Q3 2018 | 2018-09-30 | −$1.5M | $58,000 | — | — |
| Q2 2018 | 2018-06-30 | −$1.7M | $771,000 | — | — |
| Q1 2018 | 2018-03-31 | −$1.7M | $583,000 | — | — |
| Q4 2017 | 2017-12-31 | −$2.2M | −$301,000 | — | −6013.51% |
| Q3 2017 | 2017-09-30 | −$1.5M | $403,000 | — | — |
| Q2 2017 | 2017-06-30 | −$2.5M | −$228,000 | — | — |
| Q1 2017 | 2017-03-31 | −$2.3M | $117,000 | — | — |
| Q4 2016 | 2016-12-31 | −$1.9M | — | — | −14800.00% |
| Q3 2016 | 2016-09-30 | −$1.9M | — | — | — |
| Q2 2016 | 2016-06-30 | −$2.2M | — | — | — |
| Q1 2016 | 2016-03-31 | −$2.4M | — | — | — |
Bio-Path Holdings free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$8.5M to −$15.1M, a net decrease of $6.6M. Bio-Path Holdings's latest reported quarter, Q3 2022, generated −$3.4M in free cash flow, a decrease of $1.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bio-Path Holdings filings at SEC.gov ↗